MedInsights Unleashed

RASolute 302: The First Major Breakthrough in Pancreatic Cancer in Decades

42 min · 4 de jun de 2026
Portada del episodio RASolute 302: The First Major Breakthrough in Pancreatic Cancer in Decades

Descripción

The RASolute 302 trial represents a breakthrough in pancreatic cancer treatment, successfully doubling patient survival compared with standard care. In this episode of MedInsights Unleashed, Prof. Philip Philip, Professor of Medical Oncology, Wayne State University School of Medicine and Henry Ford Cancer Institute, discusses how targeting KRAS mutations may change the treatment landscape for pancreatic cancer, reviews the final ASCO analysis, and explains what these findings mean for patients, caregivers, and clinicians. While not a cure, the study offers new hope by extending survival, improving quality of life, and opening the door to a new era of targeted therapy research.

Comentarios

0

Sé la primera persona en comentar

¡Regístrate ahora y únete a la comunidad de MedInsights Unleashed!

Prueba gratis

Empieza 7 días de prueba

$99 / mes después de la prueba. · Cancela cuando quieras.

  • Podcasts solo en Podimo
  • 20 horas de audiolibros al mes
  • Podcast gratuitos

Todos los episodios

40 episodios

episode Rethinking Advanced Thyroid Cancer: Neoadjuvant Therapy and the Future of Surgery artwork

Rethinking Advanced Thyroid Cancer: Neoadjuvant Therapy and the Future of Surgery

In this episode of MedInsights Unleashed, John Collins speaks with Professor Gregory Randolph MD, FACS, FACE, Bertucci Chair in Thyroid Surgical Oncology at Harvard Medical School, about the evolving role of neoadjuvant therapy in advanced thyroid cancer. The discussion explores the challenges of locally invasive thyroid cancer and how neoadjuvant lenvatinib prior to surgery may help improve surgical outcomes, reduce morbidity, and preserve critical structures such as the recurrent laryngeal nerve. The conversation also highlights findings from a multicenter Phase 2 clinical trial, including promising results related to nerve preservation, vocal cord recovery, and the future of multidisciplinary thyroid cancer care.

26 de may de 202641 min
episode CPR, CPR-102, AEDs, and DNRs: What Everyone Should Know in an Emergency artwork

CPR, CPR-102, AEDs, and DNRs: What Everyone Should Know in an Emergency

In this episode of MedInsights Unleashed, John Collins speaks with Devin Hinchcliffe about one of the most important life-saving interventions in medicine and emergency care — CPR. The discussion explores CPR fundamentals, CPR-102 updates, AED use, DNR considerations, and why rapid intervention by both healthcare professionals and members of the community can significantly improve outcomes during cardiac emergencies. Drawing from his experience in Emergency Medical Services, law enforcement, and EMS education, Devin provides practical insights into emergency response, first responder training, and the importance of public awareness and preparedness. This episode offers valuable information for healthcare professionals, caregivers, first responders, and members of the public who want a better understanding of CPR and emergency response.

19 de may de 202640 min
episode Beyond Aortic Valve Replacement: Understanding Flow Dynamics and the Role of DurAVR THV artwork

Beyond Aortic Valve Replacement: Understanding Flow Dynamics and the Role of DurAVR THV

In this episode of MedInsights Unleashed, Wayne Paterson, Vice Chairman and CEO of Anteris Technologies, joins us to discuss one of the fastest evolving areas in structural heart disease — whether the future of valve replacement lies not only in replacing diseased valves, but also in restoring more natural heart flow. The discussion explores aortic stenosis, the evolution of TAVR, and the emerging science and MRI data surrounding DurAVR THV, including the potential importance of flow dynamics, laminar flow, durability, and long-term valve performance. We also discuss patient selection, future valve innovation, and how next-generation technologies may move beyond simply treating obstruction toward restoring more natural cardiovascular physiology.

11 de may de 202630 min
episode The Prescription Journey: What Really Happens After Your Doctor Writes the Script artwork

The Prescription Journey: What Really Happens After Your Doctor Writes the Script

In this episode of MedInsights Unleashed, John Collins speaks with Patrick Coyle, MBA, about the often-overlooked journey patients face after receiving a prescription. The conversation explores the complex system behind drug access—including insurance coverage, copays, prior authorizations, and the role of pharmacies. Patrick provides insight into how financial and operational factors influence whether patients ultimately receive their prescribed treatment. The discussion also highlights key differences between branded and generic medications, the growing challenges in specialty therapies like oncology, and the importance of patient advocacy. This episode offers practical guidance for patients and caregivers on how to navigate the system, ask the right questions, and better understand the realities behind prescription access.

27 de abr de 202648 min